ArticleCancers2022

Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade.

Rebecca Marcus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.